NASDAQ:TTOO T2 Biosystems (TTOO) Stock Price, News & Analysis $0.0006 0.00 (0.00%) As of 09/18/2026 02:39 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsInsider TradesSEC Filings About T2 Biosystems Stock (NASDAQ:TTOO) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get T2 Biosystems alerts:Sign Up Key Stats Today's Range$0.0006▼$0.000650-Day Range N/A52-Week Range$0.00▼$0.08Volume1,005 shsAverage Volume9,556 shsMarket Capitalization$12.63 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview T2 Biosystems, Inc. is a diagnostics company focused on developing and commercializing rapid molecular tests for the detection of sepsis-causing pathogens and antimicrobial resistance. Its products are designed to identify infectious organisms directly from blood samples, helping healthcare providers make treatment decisions more quickly than with traditional culture-based methods. The company’s portfolio includes the T2Dx Instrument, an automated diagnostic platform, along with tests such as T2Candida, T2Bacteria, T2Resistance and T2Biothreat. These assays are intended to detect specific pathogens and resistance markers associated with bloodstream infections, sepsis and other serious infectious diseases. T2 Biosystems also develops additional diagnostic applications based on its proprietary T2 Magnetic Resonance technology. Founded in 2006 and headquartered in Lexington, Massachusetts, T2 Biosystems serves hospitals, clinical laboratories and other healthcare providers in the United States and international markets. The company’s products are marketed through a combination of direct sales and distribution relationships, with regulatory clearances and commercial availability varying by geography.AI Generated. May Contain Errors. Read More Receive TTOO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for T2 Biosystems and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TTOO Stock News HeadlinesT2 Biosystems (NASDAQ:TTOO) Stock Price Crosses Above 50 Day Moving Average - Here's What HappenedSeptember 18 at 2:42 AM | americanbankingnews.comT2 Biosystems Inc.May 19, 2026 | marketwatch.comSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely. | Altimetry (Ad)T2 Biosystems, Inc. Announces Intent to Complete Winding Down of OperationsFebruary 3, 2026 | finance.yahoo.comT2 Biosystems Inc. (TTOO): 2025 Product Pipeline and Strategy Analysis ReportOctober 21, 2025 | finance.yahoo.comTTOO T2 Biosystems, Inc. - Seeking AlphaJune 25, 2025 | seekingalpha.comT2 Biosystems Inc. (TTOO) After Hours QuoteJune 10, 2025 | nasdaq.comT2 Biosystems initiates major layoffs, seeks asset saleFebruary 22, 2025 | uk.investing.comSee More Headlines TTOO Stock Analysis - Frequently Asked Questions How have TTOO shares performed this year? T2 Biosystems' stock was trading at $0.0050 at the beginning of the year. Since then, TTOO shares have decreased by 88.0% and is now trading at $0.0006. How were T2 Biosystems' earnings last quarter? T2 Biosystems, Inc. (NASDAQ:TTOO) announced its earnings results on Monday, July, 29th. The medical equipment provider reported ($0.66) EPS for the quarter, topping analysts' consensus estimates of ($0.97) by $0.31. The medical equipment provider earned $1.95 million during the quarter. Read the conference call transcript. When did T2 Biosystems' stock split? T2 Biosystems's stock reverse split on the morning of Friday, October 13th 2023.The 1-100 reverse split was announced on Friday, October 13th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, October 13th 2023. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split. When did T2 Biosystems IPO? T2 Biosystems (TTOO) raised $83 million in an initial public offering on Wednesday, August 6th 2014. The company issued 5,200,000 shares at a price of $15.00-$17.00 per share. How do I buy shares of T2 Biosystems? Shares of TTOO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of T2 Biosystems own? Based on aggregate information from My MarketBeat watchlists, some other companies that T2 Biosystems investors own include NVIDIA (NVDA), Meta Platforms (META), CrowdStrike (CRWD), Digital Turbine (APPS) and Tesla (TSLA). Company Calendar Last Earnings7/29/2024Today9/21/2026Next Earnings (Estimated)11/13/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:TTOO CIK1492674 Webwww.t2biosystems.com Phone(781) 761-4646Fax781-357-3080Employees113Year Founded2006Profitability EPS (Trailing Twelve Months)($3.89) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$50.08 million Net Margins-563.16% Pretax Margin-559.52% Return on EquityN/A Return on Assets-174.06% Debt Debt-to-Equity RatioN/A Current Ratio0.40 Quick Ratio0.24 Sales & Book Value Annual Sales$7.68 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($6.91) per share Price / Book0.00Miscellaneous Outstanding Shares21,043,000Free Float21,037,000Market Cap$12.63 thousand OptionableNo Data Beta7.90 Social Links 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (NASDAQ:TTOO) was last updated on 9/21/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding T2 Biosystems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share T2 Biosystems With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
